Aclaris Therapeutics (ACRS) Reports $1.36M Stock Sale by Insider
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowLeonard Braden Michael sold $1.36 million worth of stock in Aclaris Therapeutics (ACRS). This transaction adds to the ongoing scrutiny of insider trading activities at the company. The sale signifies potential shifts in the company's stock sensitivity to insider activities, which can influence investor sentiment. The impact of such insider sales on market perceptions often varies and depends on the overall performance and outlook of Aclaris Therapeutics.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
